XERS logo

Xeris Biopharma Holdings, Inc. (XERS) Inventory

annual inventory:

$48.17M+$9.34M(+24.04%)
December 31, 2024

Summary

  • As of today (September 16, 2025), XERS annual inventory is $48.17 million, with the most recent change of +$9.34 million (+24.04%) on December 31, 2024.
  • During the last 3 years, XERS annual inventory has risen by +$30.06 million (+165.90%).
  • XERS annual inventory is now at all-time high.

Performance

XERS Inventory Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherXERSbalance sheet metrics

quarterly inventory:

$67.28M+$14.59M(+27.69%)
June 30, 2025

Summary

  • As of today (September 16, 2025), XERS quarterly inventory is $67.28 million, with the most recent change of +$14.59 million (+27.69%) on June 30, 2025.
  • Over the past year, XERS quarterly inventory has increased by +$24.30 million (+56.55%).
  • XERS quarterly inventory is now -98.17% below its all-time high of $3.68 billion, reached on December 31, 2017.

Performance

XERS quarterly inventory Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherXERSbalance sheet metrics

Inventory Formula

Inventory = Beginning Inventory + Purchases − Cost of Goods Sold

XERS Inventory Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+24.0%+56.5%
3 y3 years+165.9%+276.1%
5 y5 years+2113.9%+1294.7%

XERS Inventory Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+165.9%at high+276.1%
5 y5-yearat high+2113.9%at high+1294.7%
alltimeall timeat high>+9999.0%-98.2%>+9999.0%

XERS Inventory History

DateAnnualQuarterly
Jun 2025
-
$67.28M(+27.7%)
Mar 2025
-
$52.69M(+9.4%)
Dec 2024
$48.17M(+24.0%)
$48.17M(+6.8%)
Sep 2024
-
$45.12M(+5.0%)
Jun 2024
-
$42.98M(+5.1%)
Mar 2024
-
$40.88M(+5.3%)
Dec 2023
$38.84M(+57.0%)
$38.84M(+1.8%)
Sep 2023
-
$38.14M(+4.4%)
Jun 2023
-
$36.54M(+25.8%)
Mar 2023
-
$29.04M(+17.4%)
Dec 2022
$24.73M(+36.5%)
$24.73M(+22.9%)
Sep 2022
-
$20.12M(+12.5%)
Jun 2022
-
$17.89M(+6.0%)
Mar 2022
-
$16.87M(-6.9%)
Dec 2021
$18.12M
$18.12M(+27.2%)
DateAnnualQuarterly
Sep 2021
-
$14.24M(+15.8%)
Jun 2021
-
$12.30M(-1.6%)
Mar 2021
-
$12.50M(+49.6%)
Dec 2020
$8.35M(+283.9%)
$8.35M(+48.3%)
Sep 2020
-
$5.63M(+16.8%)
Jun 2020
-
$4.82M(+122.7%)
Mar 2020
-
$2.17M(-0.5%)
Dec 2019
$2.18M(>+9900.0%)
$2.18M(>+9900.0%)
Sep 2019
-
$0.00(0.0%)
Jun 2019
-
$0.00(0.0%)
Mar 2019
-
$0.00(0.0%)
Dec 2018
$0.00(0.0%)
$0.00(0.0%)
Sep 2018
-
$0.00(0.0%)
Mar 2018
-
$0.00(-100.0%)
Dec 2017
$0.00(0.0%)
$3.68B
Dec 2016
$0.00
-

FAQ

  • What is Xeris Biopharma Holdings, Inc. annual inventory?
  • What is the all time high annual inventory for Xeris Biopharma Holdings, Inc.?
  • What is Xeris Biopharma Holdings, Inc. annual inventory year-on-year change?
  • What is Xeris Biopharma Holdings, Inc. quarterly inventory?
  • What is the all time high quarterly inventory for Xeris Biopharma Holdings, Inc.?
  • What is Xeris Biopharma Holdings, Inc. quarterly inventory year-on-year change?

What is Xeris Biopharma Holdings, Inc. annual inventory?

The current annual inventory of XERS is $48.17M

What is the all time high annual inventory for Xeris Biopharma Holdings, Inc.?

Xeris Biopharma Holdings, Inc. all-time high annual inventory is $48.17M

What is Xeris Biopharma Holdings, Inc. annual inventory year-on-year change?

Over the past year, XERS annual inventory has changed by +$9.34M (+24.04%)

What is Xeris Biopharma Holdings, Inc. quarterly inventory?

The current quarterly inventory of XERS is $67.28M

What is the all time high quarterly inventory for Xeris Biopharma Holdings, Inc.?

Xeris Biopharma Holdings, Inc. all-time high quarterly inventory is $3.68B

What is Xeris Biopharma Holdings, Inc. quarterly inventory year-on-year change?

Over the past year, XERS quarterly inventory has changed by +$24.30M (+56.55%)
On this page